| Name | Title | Contact Details |
|---|
Emerald Heights, sponsored by Emerald Communities, is a nonprofit 501(c)(3) senior housing and service organization that provides its residents programs to cultivate culture, vitality and independence. The community is a Type A Continuing Care Retirement Community (CCRC) that accommodates residents`changing needs throughout the aging process. Situated on 38 acres in the Education Hill area of Redmond, Wash., just 17 miles northeast of Seattle, Emerald Heights is an amenity-rich and resort-style senior living community, plus an assisted living facility and a Medicare-certified skilled nursing health center. The campus opened in 1992 to provide housing and service to people ages 55 and older in the aspects of independent, assisted living and skilled nursing.
We specialize in fresh, organic, perfectly-portioned meals delivered to your home or office so you can get back to feeling really, really good again.
As part of the Manning Regional Healthcare Center`s comprehensive total health care system, the Hospital has state-of-the-art diagnostic radiology equipment, emergency department care, inpatient medical and surgical treatment and skilled nursing services. All of this and much more allows us to care for the majority of your medical needs right here in Manning.
THE KRONOS GROUP is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.